# A Study on the Effect of CGM Alone on Glycemic Metrics in Type 2 Diabetes Patients Not Using Insulin, Without Additional Interventions

Study · id `cardio:ct-nct07298850` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07298850](<https://clinicaltrials.gov/study/NCT07298850>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07298850

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 120 participants.

## Technical summary

Registry record NCT07298850. Allocation not applicable; no masking; primary purpose treatment. Start 2024-09-30 (actual); primary completion 2025-07-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT07298850, source copy `cardio:ctgov-nct07298850-2025-12-23`, retrieved 2026-10-26)
- Started: 2024-09-30 (actual) (ClinicalTrials.gov record NCT07298850, source copy `cardio:ctgov-nct07298850-2025-12-23`, retrieved 2026-10-26)
- Primary completion: 2025-07-30 (actual) (ClinicalTrials.gov record NCT07298850, source copy `cardio:ctgov-nct07298850-2025-12-23`, retrieved 2026-10-26)
- Completion: 2025-12 (anticipated) (ClinicalTrials.gov record NCT07298850, source copy `cardio:ctgov-nct07298850-2025-12-23`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT07298850, source copy `cardio:ctgov-nct07298850-2025-12-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07298850-2025-12-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study on the Effect of CGM Alone on Glycemic Metrics in Type 2 Diabetes Patients Not Using Insulin, Without Additional Interventions
- Condition: Continuous Glucose Monitoring
- Condition: Type 2 Diabetes
- Intervention (Device): Continuous glucose monitoring
- Lead sponsor: Kangbuk Samsung Hospital
- Lead sponsor class: OTHER
- Collaborator: i-SENS, Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Kangbuk Samsung Hospital (`cardio:org-kangbuk-samsung-hospital`)

## Provenance

Content hash: 052ae6eeb9dcc01cfe20a48c2a90ce16dd0899f79fdaa45d04aefc6e78653091
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
